why choose us

First received: September 07, 2023

Clinical Trial: A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney Function

Study Status: Completed

Recruit Status: RECRUITING

Condition: Renal Impairment

Study Type: INTERVENTIONAL


Official Title: A PHASE 1, OPEN-LABEL, NON-RANDOMIZED, SINGLE-DOSE, PARALLEL GROUP STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF PF-07923568 IN ADULT PARTICIPANTS WITH RENAL IMPAIRMENT AND HEALTH

Brief Summary: The purpose of this study is to understand how the loss of kidney function affects study medicine (PF-07923568) in the body.People with some level of loss of kidney function may process PF-07923568 differently from healthy people.PF-07923568 is developed as a possible treatment for respiratory syncytial virus (RSV) infection.RSV is a common virus that affects the lungs and usually causes mild, cold-like symptoms.RSV can cause severe lung infections in infants, elderly, and adults with other serious medical…

Read more